BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Recent filings

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: J.Basic and diluted ... - April 1, 2019

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: J.Basic and diluted ... - March 29, 2019

Regulation FD - March 12, 2019

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 35,885 shares - March 8, 2019

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 3,501 shares - Feb. 22, 2019

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 1,475 shares - Jan. 8, 2019

Securities to be offered to employees in employee benefit plans - Dec. 21, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just cashed-in 121,558 options - Dec. 21, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s EVP and Chief Business Officer was just granted 13,333 options - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 25,333 options - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 3,667 shares - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 2,000 shares - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 8  -SUBSEQUENT ... - Oct. 29, 2018

BRAINSTORM CELL THERAPEUTICS INC. releases salary data. CEO sees compensation rise 81% - Oct. 10, 2018

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 28, 2018

Registration statement under Securities Act of 1933 - Sept. 21, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s Chief Commercial Officer just disposed of 2,805 shares - Sept. 4, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks just picked up 31,185 shares - July 27, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 9 - SUB... - July 23, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Received a Notice of Effectiveness - June 29, 2018

Notice of Exempt Offering of Securities, item 06b - June 20, 2018

Registration statement under Securities Act of 1933 - June 8, 2018

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - June 7, 2018

Entry into a Material Definitive - June 7, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 1,249 shares - March 26, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 35,885 shares - March 26, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 5,700 shares - March 20, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 5,000 shares - March 20, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 5,700 shares - March 16, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: J. Basic... - March 8, 2018

Departure of Directors or Certain - Feb. 5, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - Feb. 5, 2018

On January - Jan. 4, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s CFO and Treasurer just picked up 25,000 shares - Nov. 20, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s CFO and Treasurer just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - Nov. 20, 2017

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 2,000 shares - Nov. 13, 2017

BRAINSTORM CELL THERAPEUTICS: Appoints Eyal Rubin As Chief Financial Officer - Nov. 3, 2017

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: A summary of the C... - Oct. 17, 2017

BRAINSTORM CELL THERAPEUTICS INC. releases salary data. CEO sees compensation rise 4% - Sept. 14, 2017

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 2,500 shares - Aug. 31, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s EVP & Chief Business Officer just picked up 2,000 shares - Aug. 23, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks just picked up 31,185 shares - July 26, 2017

Entry into a Material Definitive - July 26, 2017

BRAINSTORM CELL THERAPEUTICS: Brainstorm Awarded $16 Million Non-Dilutive Grant From Cirm In Support Of Phase 3 Clinical Trial Of Nurown - July 21, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s EVP & Chief Business Officer just picked up 5,543 shares - July 17, 2017

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 12,000 options - July 17, 2017

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 1    -    GE... - May 15, 2017

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: K. Basic ... - March 29, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - March 6, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 35,885 shares - March 6, 2017

BRAINSTORM CELL THERAPEUTICS: Brainstorm Strengthens Management Team With Appointment Of Ralph Z. Kern, Md, Mhsc As Chief Operating Officer And Chief Medical Officer - March 6, 2017

BRAINSTORM CELL THERAPEUTICS INC. director just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - March 3, 2017

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 3,012 shares - March 3, 2017

BRAINSTORM CELL THERAPEUTICS: Brainstorm Names Dr. June S. Almenoff And Arturo O. Araya To Its Board Of Directors As Company Prepares For Clinical And Commercial Success - March 2, 2017

BRAINSTORM CELL THERAPEUTICS: Brainstorm To Host Year End Call With Investors To Discuss Important Corporate Developments - Dec. 19, 2016

BRAINSTORM CELL THERAPEUTICS: International Symposium On Als/Mnd, Being Held December 7-9, 2016 In Dublin, Ireland - Dec. 9, 2016

Departure of Directors or Certain - Dec. 5, 2016

BRAINSTORM CELL THERAPEUTICS INC. Just Received a Notice of Effectiveness - Nov. 21, 2016

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks just declared 4,000 options - Nov. 16, 2016

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: A. Unaudi... - Nov. 14, 2016

Post-Effective amendments for registration statement - Nov. 14, 2016

Securities to be offered to employees in employee benefit plans - Sept. 20, 2016

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 12, 2016

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: A. Unau... - Aug. 11, 2016

Brainstorm Cell Therapeutics Reports Second Quarter 2016 Financial Results And Provides Corporate Update - Aug. 11, 2016

BRAINSTORM CELL THERAPEUTICS: Brainstorm To Announce Top Line Results From The U.S. Phase 2 Study Of - July 18, 2016

Entry into a Material Definitive - June 24, 2016

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 8,666 shares - June 23, 2016

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 25,333 options - June 23, 2016

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 16,666 options - June 23, 2016

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 15,333 options - June 23, 2016

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 8,666 shares - June 23, 2016

BRAINSTORM CELL THERAPEUTICS INC.'s Chief Operating Officer was just granted 13,333 options - June 23, 2016

Submission of Matters to a Vote of Security - June 22, 2016

Other definitive proxy statements - May 11, 2016

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - May 10, 2016

Brainstorm Cell Therapeutics Reports First Quarter 2016 Financial Results And Provides Corporate Update - May 10, 2016

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - May 10, 2016

Quarterly report [Sections 13 or 15(d)] - May 10, 2016

Other preliminary proxy statements - April 22, 2016

BRAINSTORM CELL THERAPEUTICS: And Provides Business Update - March 10, 2016

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: K. Basi... - March 9, 2016

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of BRAINSTORM CELL THERAPEUTICS INC. - Jan. 12, 2016

BRAINSTORM CELL THERAPEUTICS: Clinical Data Suggest That Nurown Can Slow Disease Progression In Als - Jan. 11, 2016

BRAINSTORM CELL THERAPEUTICS INC. director just disposed of 10,800 shares - Dec. 17, 2015

BRAINSTORM CELL THERAPEUTICS INC. director just cashed-in 5,000 options - Dec. 16, 2015

BRAINSTORM CELL THERAPEUTICS INC. director just disposed of 41,742 shares - Dec. 16, 2015

BRAINSTORM CELL THERAPEUTICS INC. director just disposed of 13,480 shares - Dec. 14, 2015

BRAINSTORM CELL THERAPEUTICS INC. director just disposed of 10,800 shares - Dec. 14, 2015

BRAINSTORM CELL THERAPEUTICS INC.'s Chief Financial Officer was just granted 82,500 options - Dec. 3, 2015

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 17, 2015

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks was just granted 369,619 options - Oct. 13, 2015

BRAINSTORM CELL THERAPEUTICS INC. insider just picked up 2,000 shares - Oct. 2, 2015

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks was just granted 369,619 options - Oct. 1, 2015

BRAINSTORM CELL THERAPEUTICS INC. insider just picked up 9,200 shares - Oct. 1, 2015

BRAINSTORM CELL THERAPEUTICS: Brainstorm Announces Appointment Of Chaim Lebovits As Chief Executive Officer - Sept. 28, 2015

BRAINSTORM CELL THERAPEUTICS: Written Communications Pursuant To Rule 425 Under The Securities Act (17 Cfr 230.425) - Sept. 4, 2015

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 8,666 shares - Aug. 31, 2015

BRAINSTORM CELL THERAPEUTICS INC.'s Chief Operating Officer was just granted 13,333 options - Aug. 31, 2015

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 15,333 options - Aug. 31, 2015

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. SABBY MANAGEMENT, LLC 929,725 0.4 June 30, 2018
2. VANGUARD GROUP INC 694,231 N/A Sept. 30, 2018
3. VANGUARD GROUP INC 694,231 N/A Sept. 30, 2018
4. VANGUARD GROUP INC 686,606 N/A Dec. 31, 2018
5. RENAISSANCE TECHNOLOGIES LLC 182,457 N/A Dec. 31, 2018
6. RENAISSANCE TECHNOLOGIES LLC 182,457 N/A Dec. 31, 2018
7. RENAISSANCE TECHNOLOGIES LLC 182,457 N/A Dec. 31, 2018
8. RENAISSANCE TECHNOLOGIES LLC 133,900 N/A Sept. 30, 2018
9. GEODE CAPITAL MANAGEMENT, LLC 105,273 N/A Dec. 31, 2018
10. DEUTSCHE BANK AG\ 98,590 N/A Dec. 31, 2017
11. SUSQUEHANNA INTERNATIONAL GROUP, LLP 87,323 N/A Dec. 31, 2017
12. BlackRock Inc. 85,294 N/A Dec. 31, 2018
13. BlackRock Inc. 85,068 N/A Sept. 30, 2018
14. BlackRock Inc. 83,854 N/A Dec. 31, 2017
15. BlackRock Inc. 80,755 N/A June 30, 2017
16. Psagot Investment House Ltd. 55,241 N/A Dec. 31, 2018
17. BlackRock Fund Advisors 41,829 N/A Sept. 30, 2016
18. NORTHERN TRUST CORP 36,496 N/A June 30, 2018
19. NORTHERN TRUST CORP 36,496 N/A June 30, 2018
20. NORTHERN TRUST CORP 36,496 N/A June 30, 2018
21. NORTHERN TRUST CORP 34,223 N/A March 31, 2018
22. DEUTSCHE BANK AG\ 29,912 N/A March 31, 2018
23. Crow Point Partners, LLC 26,829 N/A Dec. 31, 2018
24. BlackRock Institutional Trust Company, N.A. 24,789 N/A Dec. 31, 2016
25. SUSQUEHANNA INTERNATIONAL GROUP, LLP 22,551 N/A June 30, 2018
26. TFS CAPITAL LLC 20,938 N/A June 30, 2017
27. BANK OF AMERICA CORP /DE/ 20,000 N/A June 30, 2018
28. SUSQUEHANNA INTERNATIONAL GROUP, LLP 19,281 N/A Sept. 30, 2018
29. JPMORGAN CHASE & CO 16,594 N/A Sept. 30, 2017
30. BANK OF AMERICA CORP /DE/ 15,064 N/A Sept. 30, 2017

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

140
 


Feedback